You are here
Products
GATA3 [C11]
![](https://abc.antibodychain.com/sites/default/files/xAnimal_friendly.png.pagespeed.ic.81e5_Bn7-w.png)
![](https://abc.antibodychain.com/sites/default/files/x10_14_days.png.pagespeed.ic.pb-AsIrVE1.png)
Product group: | Primary |
Monoclonal/ Polyclonal: | Monoclonal |
Clone: | C11 |
Host: | Mouse |
Isotype: | IgG1 |
Application: | ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blot (WB) |
Application notes: | Prediluted |
Conjugation Type: | Unconjugated |
Lightchain type: | Kappa |
Reactivity: | Human, Mouse, Rat |
General notes: | Localization: nucleus. |
Buffer: | citrate pH6.0 or EDTA pH8.0 |
UNSPSC code: | 12352203 |
GATA-3 (GATA binding protein 3) is a member of the GATA family of transcription factors. This 50kD anuclear protein regulates the development and subsequent maintenance of a variety of human tissues, including hematopoietic cells, skin, kidney, mammary gland, and the central nervous system. Among several other roles, GATA-3 involved in luminal cell differentiation in the mammary gland and appears to control a set of genes involved in the differentiation and proliferation of breast cancer. The expression of GATA-3 is associated with the expression of estrogen receptor-alpha (ER) in breast cancer. GATA-3 has been shown to be a novel marker for bladder cancer. The study demonstrated that GATA-3 stained 67% of urothelial Carcinomas, but none of prostate or renal carcinomas. (Shipping Cost: €200.00)
GATA3 [C11]
GATA-3 (GATA binding protein 3) is a member of the GATA family of transcription factors. This 50kD anuclear protein regulates the development and subsequent maintenance of a variety of human tissues, including hematopoietic cells, skin, kidney, mammary gland, and the central nervous system. Among several other roles, GATA-3 involved in luminal cell differentiation in the mammary gland and appears to control a set of genes involved in the differentiation and proliferation of breast cancer. The expression of GATA-3 is associated with the expression of estrogen receptor-alpha (ER) in breast cancer. GATA-3 has been shown to be a novel marker for bladder cancer. The study demonstrated that GATA-3 stained 67% of urothelial Carcinomas, but none of prostate or renal carcinomas.
Alternative names: